Publications
5491 Results
- Journal / Conference
- Breast Cancer Research and Treatment Jun;181(2):455-463
- Year
- 2020
- Research Committee(s)
- Breast and Cancer Care Delivery
- PMID
- PMID32306168
- PMC
- PMC8218818
- Study Number(s)
- S0012, S0221, S0226, S0307, S0500
Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials
- Journal / Conference
- Journal of Clinical Oncology Jul 1;38(19):2122-2129; May 5;JCO1902699. doi: 10.1200/JCO.19.02699. Online ahead of print.
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID32369401
- PMC
- PMC7325363
- Study Number(s)
- S1105
Randomized Trial of Text-Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer: SWOG S1105
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 4004); American Society of Clinical Oncology 2020 Annual Meeting, oral
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80702
Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Duration Evaluation of Adj chemotherapy) collaboration
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 9623); American Society of Clinical Oncology Annual Meeting (5/29/2020 - 6/2/2020, Chicago, IL), poster session
- Year
- 2020
- Research Committee(s)
- Lung
- Study Number(s)
- S1400F
SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 4504); American Society of Clinical Oncology Annual Meeting (5/29/2020 - 6/2/2020, Chicago, IL), oral
- Year
- 2020
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1505
SWOG S1505: Results of Perioperative Chemotherapy with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 1073); American Society of Clinical Oncology 2020 Annual Meeting, poster session
- Year
- 2020
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Metaplastic Carcinoma of the Breast: DART (SWOG S1609, Cohort 36)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 1001); American Society of Clinical Oncology 2020 Annual Meeting, oral
- Year
- 2020
- Research Committee(s)
- Breast
- Study Number(s)
- S1416
Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline BRCA-associated breast cancer (SWOG S1416)
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr 7010); American Society of Clinical Oncology 2020 Annual Meeting, poster discussion
- Year
- 2020
- Research Committee(s)
- Cancer Care Delivery
- Study Number(s)
- S1417CD
Cumulative Incidence of Financial Hardship in Metastatic Colorectal Cancer (mCRC) Patients (pts): Primary Endpoint Results for SWOG S1417CD
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr TPS10090); American Society of Clinical Oncology 2020 Annual Meeting, TIPS poster
- Year
- 2020
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1801
S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma
- Journal / Conference
- J Clin Oncol 38: 2020 (suppl; abstr TPS8067); American Society of Clinical Oncology 2020 Annual Meeting, TIPS poster
- Year
- 2020
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826